Science Pool

Fast and Easy In Vitro Tox in PanHunter

Posted by Evotec on Jul 5, 2021 1:58:28 PM

Tags: Videos & Webinars, In vitro Biology, Toxicology & Safety

Human iPSC-Derived Mixed CNS Cells Fact Sheet

Posted by Evotec on Jun 21, 2021 12:01:21 PM

Learn more about Human iPSC-Derived Mixed CNS Cells and their advantages including:

  • Highly physiological neural networks
  • Long term synchronous network activity
  • Suitable as seizure liability mode
DOWNLOAD

Tags: Neuroscience, Fact Sheets, Hit & Target ID/Validation, Biologics, In vitro Biology, Toxicology & Safety

Human iPSC-Derived Cardiomyocyte Fact Sheet

Posted by Evotec on Jun 21, 2021 12:00:42 PM

Learn more about the advantages of human iPSC-derived cardiomyocytes including:

  • Predictive and physiological cell model
  • Applicable for drug development, preclinical research, and cardiac safety assessment
  • Quantity, consistency and efficiency for HTS
DOWNLOAD

Tags: Fact Sheets, Hit & Target ID/Validation, Biologics, In vitro Biology, Toxicology & Safety

In Vitro iPSC Research Services Fact Sheet

Posted by Evotec on Jun 21, 2021 11:59:53 AM

Learn more about in Vitro iPSC research services at Evotec including:

  • Robust differentiation protocols or adaptation of client protocols
  • High-quality production of iPSC-derived cells at large scale
  • Disease-relevant phenotypic read-outs for exploratory research and compound profiling/HTS
  • Proprietary iPSC patent portfolio in tissue and disease modeling
DOWNLOAD

Tags: Fact Sheets, Hit & Target ID/Validation, Biologics, In vitro Biology, Toxicology & Safety

Dual Detection of Functional and Structural Cardiotoxicity

Posted by Evotec on Jun 16, 2021 10:39:39 AM

Cardiotoxic drugs can display acute alteration in the mechanical function of the myocardium (functional changes) or morphological damage to cardiomyocytes and/or loss of viability (structural changes).   

In this poster, we focus on:

  • the detection of functional cardiomyocyte changes through monitoring of calcium transients using human iPSC-derived cardiomyocytes
  • the analysis of structural morphology using high content imaging (calcium homeostasis and mitochondrial function) as well as cellular ATP in human iPSC-derived cardiomyocytes
  • the presentation of a strategy for understanding cardiotoxicity risk for novel compounds enabling in vitro to in vivo translation at an early stage in preclinical screening.

Read our poster to learn more about our research!

LEARN MORE

 

Tags: Posters, IND Enabling Studies/Preclinical Development, Toxicology & Safety

Improving the Prediction of Mitochondrial Toxicity

Posted by Evotec on Mar 7, 2021 1:57:23 PM

Drug-induced mitochondrial dysfunction has been associated with organ toxicity and drug withdrawal. Highly specific and sensitive in vitro assays have been developed to predict mitochondrial dysfunction.

In this publication, we focus on:

  • a background to mitochondrial toxicity
  • a comparison of the Glu/Gal mitochondrial assay with the Seahorse assay for the prediction of mitochondrial toxicity
  • how the Seahorse assay provides a mechanistic understanding of mitochondrial toxicity

Read our publication to learn more!

LEARN MORE

Tags: Articles & Whitepapers, Toxicology & Safety

Strategies to Minimise the Risk of DILI

Posted by Evotec on Mar 7, 2021 1:24:04 PM

Drug-induced liver injury (DILI) is a leading cause of drug failure due to poor translation between traditional preclinical animal models and human clinical outcome. More sophisticated human in vitro cell-based models with multiparametric endpoints are now being developed to improve DILI prediction.

In this review article, we focus on:

  • the evolution of the strategies adopted to improve human hepatotoxicity prediction in drug discovery
  • how companies are addressing translational challenges using human relevant cell-based models
  • a further insight into the key role of human exposure and hepatic drug uptake transporters (e.g., OATPs, OAT2)

Read our publication to learn more!

LEARN MORE

Tags: Articles & Whitepapers, Toxicology & Safety

The Future of MEA in Early Toxicology Assessment

Posted by Evotec on Mar 7, 2021 1:11:12 PM

It is almost 50 years since MEA was first developed, however, the power of this technology in toxicology testing has only just been realised due to the introduction of the multi-well MEA allowing for its utility in high throughput
analysis.

In this whitepaper, we focus on:

  • the current challenges within the pharmaceutical industry in terms of toxicology prediction
  • how companies are addressing these challenges using human relevant cell-based models
  • an in-depth evaluation of microelectrode array (MEA) and its key role in in vitro cardiotoxicity and neurotoxicity toxicology testing

Read our whitepaper to learn more!

LEARN MORE

Tags: Neuroscience, Articles & Whitepapers, Toxicology & Safety

Importance of Metabolism, PK and Toxicity in Drug Design

Posted by Evotec on Mar 6, 2021 2:26:12 PM

Tags: Articles & Whitepapers, ADME/DMPK, Toxicology & Safety

Toxicology Prediction via Panomics DDup #10

Posted by Evotec on Feb 16, 2021 10:52:48 PM

Tags: Articles & Whitepapers, Toxicology & Safety